ANCILLARY SUPPLY CHAIN EXPERTISEAncillare Insights
Ancillare’s CEO, Dr. Joanne Santomauro, discusses how the organization overcame supply chain challenges in the height of the COVID-19 pandemic to source ancillary supplies for clinical trials.
Dry eye syndrome is a common condition with many ongoing studies around the globe. Read the overview by Ancillare’s Medical Director, including ancillary considerations for clinical supply chains.
This Clinical Trials Day, we are highlighting the individual areas of expertise that allows us to serve as much more than a supplier.
February is Age-Related Macular Degeneration (ARMD) and Low Vision Awareness month. Dr. Georgia Crozier, Medical Director and Subject Matter Expert at Ancillare, shares her decades of experience to raise public awareness on this common condition — and highlights the importance of a well-planned Clinical Trial Ancillary Supply Chain (CTASC™) in conducting research for potential treatments.
How Can a Supply Chain Dashboard Yield Greater Clinical Trial Insights, Cost Control, and Efficiency?
With 1 in 10 Sponsors identifying a lack of technology integration as their biggest pain point, Deighton Liverpool, Ancillare’s Chief Information Officer addresses the critical need. And dives into what Ancillare is doing to bring sophisticated Clinical Trial Ancillary Supply Chain (CTASC™) technology dashboards to its Sponsor and CRO partners.
PharmaVOICE SHOWCASE: Supply Chain Management: The Supply Chain: Risks and Opportunities with Executive Viewpoints from Ancillare’s CEO
COVID-19 caused shockwaves throughout the global supply chain of every industry. For the pharmaceutical industry, the pandemic highlighted the fragility of the supply chain and the importance of being able to adjust to demand in a changed environment.
PharmaVOICE Technology Solutions: Disrupting Innovations with Digital Solutions with Executive Viewpoints from Ancillare’s CIO
Healthcare is undergoing a massive transformation with increased emphasis on digital technologies in all areas. According to Deloitte research, biopharma companies recognize that digital transformation will aid product and service innovation, greater customer engagement, and improvements across R&D, commercial, and the supply chain.
The COVID-19 pandemic has created numerous challenges for Sponsors worldwide, forcing clinical trials to adapt to changing conditions and innovate for the future simultaneously. Ancillare CEO Dr. Joanne Santomauro was interviewed on how proper supply plans are...
With an emerging Clinical Trial Ancillary Supply Chain™, and little research into effective management models, it has never been more urgent for management systems to step up to an increasingly complex trial landscape. Today’s pharmaceutical landscape relies...
When a pharmaceutical client came to Joanne Santomauro nearly 15 years ago with a request to help with a complex and expensive ancillary supply challenge, she didn’t hesitate. She launched Ancillare and began the journey to create and revolutionize ancillary supply...
Talk with Our Ancillary Supply Chain Experts
Tell us a little about your project or ancillary supply challenges, and we will set up a consultation with our team.